| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215852 Compositions and methods for ameliorating cachexia |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 08/27/2009 | US20090214665 Controlled Release Muscarinic Receptor Antagonist Formulation |
| 08/27/2009 | CA2715486A1 Composition for modulating stem cell growth with prostaglandins |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2091531A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | CN101516390A Agent for preventing development of reflex sympathetic dystrophy after stroke |
| 08/26/2009 | CN101513466A Method for preparing quinoline alkaloid from zanthoxylum dissitum Hemsl |
| 08/26/2009 | CN100531734C Atracurium freezing-dried composition |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/20/2009 | WO2009101399A1 Treatment of muscular dystrophy using peptide nucleic acid ( pna) |
| 08/20/2009 | WO2009101137A1 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209459 Method of Treating Myasthenia Gravis |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | CN101511871A Anti-myostatin antibodies |
| 08/19/2009 | CN101511209A Novel use |
| 08/19/2009 | CN101507770A Traditional Chinese medicine composite for treating horse spasm hernia |
| 08/19/2009 | CN101507755A Preparation method of high-purity magnolia bark total-phenol |
| 08/19/2009 | CN100528875C Crystal-free type Idi prone and its preparing method |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/13/2009 | WO2009099326A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 08/13/2009 | WO2009098577A2 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 08/13/2009 | WO2009098533A1 Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 08/13/2009 | WO2009008727A3 Molecules for targeting compounds to various selected organs or tissues |
| 08/13/2009 | WO2009008725A3 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203698 Compounds for Enzyme Inhibition |
| 08/13/2009 | US20090203691 such as N1-{3-[3,5-Di(trifluoromethyl)phenyl]-1H-5-indazolyl}-(2R)-2-amino-3,3-diphenylpropanamide, having an excellent Jun N-terminal Kinase (JNK) inhibitory action, used for treating various immunologic diseases, inflammatory diseases, and/or neurodegenerative diseases |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/13/2009 | CA2714120A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 08/13/2009 | CA2713416A1 Non-immunosuppressive cyclosporin for the treatment of a muscular dystrophy |
| 08/12/2009 | EP2086524A1 Transnasal anticonvulsive pharmaceutical composition |
| 08/12/2009 | EP1515959B1 Pharmaceutical salts of reboxetine |
| 08/12/2009 | EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | CN100525831C Improved pharmaceutical botulinum toxin compositions |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572785 Substituted imidazoles as cannabinoid receptor modulators |
| 08/11/2009 | US7572774 Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds |
| 08/11/2009 | US7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
| 08/06/2009 | WO2009095378A1 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders |
| 08/06/2009 | WO2009068689A3 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders |
| 08/06/2009 | WO2009036149A3 Methods for treatment of degenerative disease associated with apoptosis |
| 08/06/2009 | US20090197930 Eyedrops |
| 08/06/2009 | US20090197858 Hypercholestrolemia and tendinous injuries |
| 08/06/2009 | US20090197820 Compositions and Methods for Improving Cardiovascular Health |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | CA2713376A1 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP1931349A4 Use of sodium channel blockers for the management of musculoskeletal pain |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1442115B1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 08/05/2009 | CN101500608A Preventive or remedy for inflammatory disease |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522233C Medicament for treating eyelid ptosis and myasthenia gravis and method for preparing same |
| 08/04/2009 | US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 07/30/2009 | US20090192222 Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090191290 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport |
| 07/30/2009 | US20090191155 Usher 1B syndrome ocular disease; delivering subretinally to target cells; expression vehicle is HIV-1; CMV-MYO7A promoter or promoter active in photoreceptor or retinal pigment epithelium (RPE) cell; polynucleotide sequence encoding myosin VIIA; chromosomal integration sequence; gene therapy; blindness |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN101495183A Treating muscular disorders and improving muscular function |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518745C Organic extract for Japonicum Thunb and application thereof |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/28/2009 | CA2370147C Piperidine-indole compounds having 5-ht6 affinity |
| 07/23/2009 | WO2008119571A3 Nucleic acid myostatin antagonist aptamers obtained by (mirror- image) selex |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186806 Truncated Activin Type II Receptor and Methods of Use |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |